Question 1

Who is the best candidate for an insulin pump?

Accepted Answer

The ADA and major clinical guidelines state that insulin pump therapy may be beneficial for all individuals with type 1 diabetes, regardless of age. Pumps are also worth considering for type 2 patients who remain above glycemic targets despite multiple daily injections. The key requirement is willingness to learn the technology and monitor closely, pump therapy rewards engaged, motivated users.[2][5]

Question 2

Can I switch back to injections after starting a pump?

Accepted Answer

Yes. Choosing one method over the other is not a lifelong commitment, and some people go on and off their pumps, but this should always be done with instructions from a person's diabetes care team. Have a transition plan ready, because your basal and bolus insulin doses on injections will differ from your pump settings.[8]

Question 3

How does the 2026 ADA guidance affect my choice?

Accepted Answer

The ADA's 2026 Standards of Care position Automated Insulin Delivery (AID) above MDI and pump therapy without automation, and remove barriers such as C-peptide minimums and auto-antibody requirements. In practical terms, this means more people are now clinically eligible for pump-based AID systems earlier in their diabetes journey, and insurers are increasingly required to align with that guidance.[2][5]

Question 4

What if I cannot afford a pump?

Accepted Answer

Start with the ADA's affordable insulin resources and contact pump manufacturers directly about patient assistance programs. Financial hardship programs from device makers can provide discounted pumps based on your income. In the meantime, an optimized MDI regimen with a continuous glucose monitor can close much of the clinical gap at a far lower cost.[6]

insulin pump

Insulin Pump vs Injections – Which Diabetes Delivery Method Fits Your Life?

Can’t wait for Minimed 670g insulin pump!

Where is the MiniMed 670G System?

Bionic Pancreas Critical Hurdle, iLet

Bionic Pancreas, Bridge To A Cure!

MiniMed 670G System Available Spring 2017

Artificial Pancreas Approved by FDA for Diabetes

CGM System by Medtronic, Winner for T1D

Artificial Pancreas Shows Promise in Type 1 Diabetes